chr5-177992735-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006261.5(PROP1):c.655C>T(p.Leu219Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000208 in 1,440,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006261.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PROP1 | NM_006261.5 | c.655C>T | p.Leu219Phe | missense_variant | 3/3 | ENST00000308304.2 | NP_006252.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PROP1 | ENST00000308304.2 | c.655C>T | p.Leu219Phe | missense_variant | 3/3 | 1 | NM_006261.5 | ENSP00000311290.2 |
Frequencies
GnomAD3 genomes Cov.: 26
GnomAD3 exomes AF: 0.00000884 AC: 2AN: 226186Hom.: 0 AF XY: 0.00000815 AC XY: 1AN XY: 122770
GnomAD4 exome AF: 0.00000208 AC: 3AN: 1440796Hom.: 0 Cov.: 32 AF XY: 0.00000279 AC XY: 2AN XY: 715774
GnomAD4 genome Cov.: 26
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2024 | The c.655C>T (p.L219F) alteration is located in exon 3 (coding exon 3) of the PROP1 gene. This alteration results from a C to T substitution at nucleotide position 655, causing the leucine (L) at amino acid position 219 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at